[ad_1]
The four countries signed an agreement with the group, which was formed in 1999 after the merger of the Swedish company Astra and the British company Zeneca. It will have to supply the vaccine to all EU members as soon as vaccines are developed, the German health ministry said.
The vaccine is slated to be successfully completed later this year, sources told the German government, AFP.
Vaccines “should be distributed to all Member States wishing to participate [pirkime], depending on the size of their populations, “said the ministry.
“For large quantities of vaccines to be available very soon after possible approval this year or next, production capacity must be guaranteed by contract now,” added SAM.
According to the World Bank, the EU currently has around € 447 million. population.
The European Commission on Friday defended the idea that Community countries should work together to ensure privileged access to the future vaccine and welcomed the possibility of concluding advance purchase agreements.
Labs are working to develop vaccines at a record rate of 12 to 18 months, rather than a few years as usual. The advance payments would allow them to invest more quickly in production, even if human clinical trials have not yet been completed.
The new agreement gives Member States the right to buy vaccines at a specified price as soon as the vaccine is available, at investment risk.
Major pharmaceutical groups are currently competing to develop a vaccine against coronavirus, which has infected more than 7.4 million people worldwide. people and more than 417 of them died.
[ad_2]
